110 related articles for article (PubMed ID: 12170059)
1. Nicotinic acetylcholine receptor regulation of spinal norepinephrine release.
Li X; Eisenach JC
Anesthesiology; 2002 Jun; 96(6):1450-6. PubMed ID: 12170059
[TBL] [Abstract][Full Text] [Related]
2. Presynaptic alpha7 and non-alpha7 nicotinic acetylcholine receptors modulate [3H]d-aspartate release from rat frontal cortex in vitro.
Rousseau SJ; Jones IW; Pullar IA; Wonnacott S
Neuropharmacology; 2005 Jul; 49(1):59-72. PubMed ID: 15992581
[TBL] [Abstract][Full Text] [Related]
3. Chronic nicotine differentially affects the function of nicotinic receptor subtypes regulating neurotransmitter release.
Grilli M; Parodi M; Raiteri M; Marchi M
J Neurochem; 2005 Jun; 93(5):1353-60. PubMed ID: 15934954
[TBL] [Abstract][Full Text] [Related]
4. Indirect modulation by alpha7 nicotinic acetylcholine receptors of noradrenaline release in rat hippocampal slices: interaction with glutamate and GABA systems and effect of nicotine withdrawal.
Barik J; Wonnacott S
Mol Pharmacol; 2006 Feb; 69(2):618-28. PubMed ID: 16269536
[TBL] [Abstract][Full Text] [Related]
5. Characterization of nicotinic acetylcholine receptors that modulate nicotine-evoked [3H]norepinephrine release from mouse hippocampal synaptosomes.
Azam L; McIntosh JM
Mol Pharmacol; 2006 Sep; 70(3):967-76. PubMed ID: 16735605
[TBL] [Abstract][Full Text] [Related]
6. Formation of 6-nitro-norepinephrine from nitric oxide and norepinephrine in the spinal cord and its role in spinal analgesia.
Chiari A; Li XH; Xu Z; Pan HL; Eisenach JC
Neuroscience; 2000; 101(1):189-96. PubMed ID: 11068147
[TBL] [Abstract][Full Text] [Related]
7. Presynaptic alpha7-nicotinic acetylcholine receptors mediate nicotine-induced nitric oxidergic neurogenic vasodilation in porcine basilar arteries.
Si ML; Lee TJ
J Pharmacol Exp Ther; 2001 Jul; 298(1):122-8. PubMed ID: 11408533
[TBL] [Abstract][Full Text] [Related]
8. Spinal mechanisms underlying A-85380-induced effects on acute thermal pain.
Rueter LE; Meyer MD; Decker MW
Brain Res; 2000 Jul; 872(1-2):93-101. PubMed ID: 10924680
[TBL] [Abstract][Full Text] [Related]
9. Release of [3H]-noradrenaline from rat hippocampal synaptosomes by nicotine: mediation by different nicotinic receptor subtypes from striatal [3H]-dopamine release.
Clarke PB; Reuben M
Br J Pharmacol; 1996 Feb; 117(4):595-606. PubMed ID: 8646402
[TBL] [Abstract][Full Text] [Related]
10. Spinal norepinephrine release from nitric oxide species is not increased following peripheral nerve injury in rats.
Zhu X; Li X; Eisenach JC
Brain Res; 2002 Aug; 947(2):199-203. PubMed ID: 12176161
[TBL] [Abstract][Full Text] [Related]
11. ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization.
Donnelly-Roberts DL; Puttfarcken PS; Kuntzweiler TA; Briggs CA; Anderson DJ; Campbell JE; Piattoni-Kaplan M; McKenna DG; Wasicak JT; Holladay MW; Williams M; Arneric SP
J Pharmacol Exp Ther; 1998 May; 285(2):777-86. PubMed ID: 9580626
[TBL] [Abstract][Full Text] [Related]
12. 6-NO(2)-norepinephrine increases norepinephrine release and inhibits norepinephrine uptake in rat spinal synaptosomes.
Li X; Rose G; Chiari A; Pan HL; Tobin JR; Eisenach JC
J Pharmacol Exp Ther; 2000 Mar; 292(3):895-9. PubMed ID: 10688602
[TBL] [Abstract][Full Text] [Related]
13. alpha-bungarotoxin-sensitive nicotinic receptors indirectly modulate [(3)H]dopamine release in rat striatal slices via glutamate release.
Kaiser S; Wonnacott S
Mol Pharmacol; 2000 Aug; 58(2):312-8. PubMed ID: 10908298
[TBL] [Abstract][Full Text] [Related]
14. Functional responses and subunit composition of presynaptic nicotinic receptor subtypes explored using the novel agonist 5-iodo-A-85380.
Mogg AJ; Jones FA; Pullar IA; Sharples CG; Wonnacott S
Neuropharmacology; 2004 Nov; 47(6):848-59. PubMed ID: 15527819
[TBL] [Abstract][Full Text] [Related]
15. A-85380 and epibatidine each interact with disparate spinal nicotinic receptor subtypes to achieve analgesia and nociception.
Khan IM; Stanislaus S; Zhang L; Taylor P; Yaksh TL
J Pharmacol Exp Ther; 2001 Apr; 297(1):230-9. PubMed ID: 11259549
[TBL] [Abstract][Full Text] [Related]
16. Nicotinic acetylcholine receptor-mediated [3H]dopamine release from hippocampus.
Cao YJ; Surowy CS; Puttfarcken PS
J Pharmacol Exp Ther; 2005 Mar; 312(3):1298-304. PubMed ID: 15542623
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of dopamine, norepinephrine and serotonin release in the rat prefrontal cortex by neuronal nicotinic acetylcholine receptor agonists.
Rao TS; Correa LD; Adams P; Santori EM; Sacaan AI
Brain Res; 2003 Nov; 990(1-2):203-8. PubMed ID: 14568345
[TBL] [Abstract][Full Text] [Related]
18. Different presynaptic nicotinic receptor subtypes modulate in vivo and in vitro the release of glycine in the rat hippocampus.
Zappettini S; Mura E; Grilli M; Preda S; Salamone A; Olivero G; Govoni S; Marchi M
Neurochem Int; 2011 Oct; 59(5):729-38. PubMed ID: 21762741
[TBL] [Abstract][Full Text] [Related]
19. Nicotinic acetylcholine receptor-mediated release of [3H]norepinephrine from developing and adult rat hippocampus: direct and indirect mechanisms.
Leslie FM; Gallardo KA; Park MK
Neuropharmacology; 2002 Apr; 42(5):653-61. PubMed ID: 11985823
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological differences between rat frontal cortex and hippocampus in the nicotinic modulation of noradrenaline release implicate distinct receptor subtypes.
Kennett A; Heal DJ; Wonnacott S
Nicotine Tob Res; 2012 Nov; 14(11):1339-45. PubMed ID: 22614547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
